Please login to the form below

Not currently logged in
Email:
Password:

CE mark

This page shows the latest CE mark news and features for those working in and with pharma, biotech and healthcare.

Time running out for ‘no-deal’ Brexit medicines laws

Time running out for ‘no-deal’ Brexit medicines laws

The proposals cover medical device regulations too, and the MHRA has suggested that devices that carry a CE mark will continue to be recognised by UK law for a time-limited

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and

  • Deal Watch June 2016 Deal Watch June 2016

    In Europe Cerus expects to apply for a CE Mark for the Intercept RBC System in the second half of 2016.

  • Pharma deals during November 2012 Pharma deals during November 2012

    The V2 is one of 5 hypertension-treating devices with a CE mark and will compete with Medtronic's “Symplicity” (acquired from Ardian for $800m) and Covidien's “OneShot” (acquired from

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics